These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32971233)

  • 21. Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.
    Hammerschmidt T; Kummer MP; Terwel D; Martinez A; Gorji A; Pape HC; Rommelfanger KS; Schroeder JP; Stoll M; Schultze J; Weinshenker D; Heneka MT
    Biol Psychiatry; 2013 Mar; 73(5):454-63. PubMed ID: 22883210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
    Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS
    FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer's Disease Model Mice.
    Ramasamy VS; Samidurai M; Park HJ; Wang M; Park RY; Yu SY; Kang HK; Hong S; Choi WS; Lee YY; Kim HS; Jo J
    Mol Neurobiol; 2020 Jan; 57(1):315-330. PubMed ID: 31332763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.
    Montgomery SL; Mastrangelo MA; Habib D; Narrow WC; Knowlden SA; Wright TW; Bowers WJ
    Am J Pathol; 2011 Oct; 179(4):2053-70. PubMed ID: 21835156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.
    Sakakibara Y; Hirota Y; Ibaraki K; Takei K; Chikamatsu S; Tsubokawa Y; Saito T; Saido TC; Sekiya M; Iijima KM
    J Alzheimers Dis; 2021; 82(4):1513-1530. PubMed ID: 34180416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer's disease.
    Panayiotou E; Fella E; Andreou S; Papacharalambous R; Gerasimou P; Costeas P; Angeli S; Kousiappa I; Papacostas S; Kyriakides T
    PLoS One; 2019; 14(12):e0225417. PubMed ID: 31809505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A noradrenergic lesion aggravates the effects of systemic inflammation on the hippocampus of aged rats.
    Bharani KL; Derex R; Granholm AC; Ledreux A
    PLoS One; 2017; 12(12):e0189821. PubMed ID: 29261743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.
    Lương Kv; Nguyen LT
    Am J Alzheimers Dis Other Demen; 2013 Aug; 28(5):427-39. PubMed ID: 23689075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease.
    Branca C; Wisely EV; Hartman LK; Caccamo A; Oddo S
    Neurobiol Aging; 2014 Dec; 35(12):2726-2735. PubMed ID: 25034342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noradrenergic dysfunction accelerates LPS-elicited inflammation-related ascending sequential neurodegeneration and deficits in non-motor/motor functions.
    Song S; Wang Q; Jiang L; Oyarzabal E; Riddick NV; Wilson B; Moy SS; Shih YI; Hong JS
    Brain Behav Immun; 2019 Oct; 81():374-387. PubMed ID: 31247288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G; Rivest S
    J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.
    Gannon M; Wang Q
    Brain Res; 2019 Jan; 1702():12-16. PubMed ID: 29307592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The β-adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease.
    Li S
    J Neurochem; 2023 May; 165(3):289-302. PubMed ID: 36799441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin B plays a critical role in inducing Alzheimer's disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice.
    Wu Z; Ni J; Liu Y; Teeling JL; Takayama F; Collcutt A; Ibbett P; Nakanishi H
    Brain Behav Immun; 2017 Oct; 65():350-361. PubMed ID: 28610747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model.
    Cai M; Lee JH; Yang EJ
    J Neuroinflammation; 2019 Dec; 16(1):264. PubMed ID: 31836020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Ponnusamy R; McNerney MW; Moghadam S; Salehi A
    Brain Res; 2019 Jan; 1702():3-11. PubMed ID: 29102776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of tormentic acid against memory impairment and neuro‑inflammation in an Alzheimer's disease mouse model.
    Cui W; Sun C; Ma Y; Wang S; Wang X; Zhang Y
    Mol Med Rep; 2020 Aug; 22(2):739-750. PubMed ID: 32468017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease.
    Bekdash RA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
    Wan W; Zhang C; Danielsen M; Li Q; Chen W; Chan Y; Li Y
    Exp Gerontol; 2016 Aug; 81():92-100. PubMed ID: 27220811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.